Shift Bioscience: Funding, Investors & Team (Sep 2026)
Shift Bioscience is using simulation guided cell rejuvenation to defeat the diseases of aging. Cellular reprogramming with Yamanaka factors can reverse aging in the dish but is not yet safe for clinical use. Shift has pioneered the first high throughput and high accuracy aging biomarker, which has been leveraged inside AI-based cell simulations to identify safer rejuvenation gene-factors. Shift envisions the development of a single drug-family that can treat multiple diseases of aging, after which full and continued health into old age becomes the norm.
Shift Bioscience has raised $16.3M across 1 funding round on record, the most recent a Seed of $16.3M announced in Oct 2024.
That round is above the $5.7M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Shift Bioscience Company Profile and Key Stats
Latest funding round on record: Oct 2024.
Shift Bioscience Funding Rounds
Shift Bioscience Founders and Leadership Team
No contact details are on record for this team yet.
Shift Bioscience Funding Compared to Other Artificial Intelligence Startups
Shift Bioscience's latest round of $16.3M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Shift Bioscience in Artificial Intelligence and Cambridge
Companies Similar to Shift Bioscience
The largest GPU Cloud purpose built for AI. Instantly deploy thousands of NVIDIA H100s and A100s on demand,…
Stability AI is developing open AI resources that enable us to maximize our capabilities. We create and…
Callosum provides data analytics, artificial intelligence, and digital engineering services for data…
Medly AI is an advanced tutor that is able to support students in multiple languages through the use of…
Mindgard is an AI security company that assists businesses in safeguarding their AI models against cyber…
Edgify is a developer of a predictive personalization technology used to analyze a user's photos on their…
The AI agents provided by Finster AI possess the ability to comprehend, evaluate, and incorporate various…
Malted AI is a company that designs a low-code platform that allows businesses to create and launch…
OLIX designs and manufactures optical processors that use light-based circuits to accelerate artificial…
Qureight is a company specializing in imaging analytics, with a goal of enhancing its analytical platform to…
Greyparrot is the leading AI waste analytics platform for the circular economy. We are on a mission to…
Founded by Dr. Sam Tukra and Callum Adamson (who have been working together since 2019) in 2023 to solve the…
Shift Bioscience Funding FAQs
What does Shift Bioscience do?
Shift Bioscience is using simulation guided cell rejuvenation to defeat the diseases of aging. Cellular reprogramming with Yamanaka factors can reverse aging in the dish but is not yet safe for clinical use. Shift has pioneered the first high throughput and high accuracy aging biomarker, which has been leveraged inside AI-based cell simulations to identify safer rejuvenation gene-factors. Shift envisions the development of a single drug-family that can treat multiple diseases of aging, after which full and continued health into old age becomes the norm.
How much funding has Shift Bioscience raised?
Shift Bioscience has raised $16.3M across 1 round on record. The most recent is a Seed of $16.3M announced in Oct 2024.
When did Shift Bioscience last raise funding?
Shift Bioscience's most recent funding round on record is a Seed of $16.3M, announced in Oct 2024.
Who founded Shift Bioscience?
FundedIQ lists Daniel Ives (Founder) at Shift Bioscience.
Where is Shift Bioscience headquartered?
Shift Bioscience is based in Cambridge, Cambridgeshire, United Kingdom.
How many employees does Shift Bioscience have?
Shift Bioscience is in the 11-50 employee band.
How does Shift Bioscience's funding compare to other Artificial Intelligence startups?
Shift Bioscience's latest round of $16.3M is above the $5.7M median round size for Artificial Intelligence companies on FundedIQ across 7,234 tracked companies over the last two years.
About FundedIQ's Shift Bioscience Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Shift Bioscience is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.